Tricuspid Valve Disease clinical trials at UCSF
2 in progress, 1 open to eligible people
Tricuspid valve disease happens when the valve on the heart's right side fails to work properly. UCSF is conducting a trial to evaluate the Edwards PASCAL Transcatheter Repair System for its safety and effectiveness. This trial seeks participants with severe symptoms needing alternative treatments.
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
open to eligible people ages 18 years and up
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team
San Francisco, California and other locations
TRISCEND II Pivotal Trial
Sorry, in progress, not accepting new patients
Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system
San Francisco, California and other locations
Our lead scientists for Tricuspid Valve Disease research studies include Sammy Elmariah, MD.
Last updated: